Septerna, Inc. (SEPN) Dividend History

Septerna, Inc. is a biotechnology company focused on developing innovative therapies targeting G protein-coupled receptors (GPCRs) to address unmet medical needs. The company leverages advanced research and proprietary technology platforms to discover and advance novel drugs in areas such as neuroscience, immunology, and metabolic diseases.

Dividend History

Septerna, Inc. currently does not pay dividends

Company News

Analysts Think These Stocks Could More Than Double in Value

Analysts believe three healthcare stocks - Septerna Inc, Intellia Therapeutics, and Novavax - have the potential to at least double in price, although they carry varying levels of risk.

Investing.com

Featured Companies: NTLA NVAX
Kirby McInerney LLP Announces Investigation Against Septerna, Inc. (SEPN) on Behalf of Investors

Kirby McInerney LLP is investigating potential claims against Septerna, Inc. (NASDAQ:SEPN) after the company announced the discontinuation of a clinical trial for its hypoparathyroidism treatment due to unexpected severe cases of elevated unconjugated bilirubin.

GlobeNewswire Inc.

Page data last updated 07/23/2025 16:56:52 UTC